Addison Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$701 Hold
50
﹤0.01% 909
2025
Q4
$562 Hold
50
﹤0.01% 862
2025
Q3
$578 Hold
50
﹤0.01% 842
2025
Q2
$612 Hold
50
﹤0.01% 834
2025
Q1
$717 Hold
50
﹤0.01% 790
2024
Q4
$796 Hold
50
﹤0.01% 792
2024
Q3
$1.2K Hold
50
﹤0.01% 763
2024
Q2
$996 Hold
50
﹤0.01% 718
2024
Q1
$996 Buy
+50
New +$967 ﹤0.01% 647

Other funds holding AVNS

Addison Advisors's AVNS Position: Q1 2026 in Review

Addison Advisors held its Avanos Medical (AVNS) position steady in Q1 2026 at 50 shares worth $701. The position accounts for ﹤0.01% of the portfolio, ranked #909.

Addison Advisors first reported a position in AVNS in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.2K in Q3 2024. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Addison Advisors held 50 shares of Avanos Medical worth $701 as of Q1 2026.
  • Addison Advisors left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of Addison Advisors's portfolio in Q1 2026, its #909 holding.
  • Addison Advisors first reported a position in Avanos Medical in Q1 2024 and has held it in 9 quarters since.
  • Addison Advisors's Avanos Medical position peaked at $1.2K in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.